MedPath

HEPAGAM B

HEPAGAM B

Approved
DIN Number

02290979

Drug Class

Human

Market Date

Aug 13, 2007

Company
HC

ki biopharma llc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02290979
AIG Number0114080004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J06BB04 HEPATITIS B IMMUNOGLOBULIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular ,  Intravenous
AHFS Classification80:04.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

HEPATITIS B IMMUNOGLOBULIN (HUMAN)Active
Strength: 312 UNIT / ML
Monograph: HEPATITIS B IMMUNOGLOBULIN (HUMAN)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.